Browse Pharmaceutical industry topic

Research subtopic

Articles 1-100 out of 100 article(s) Title Author Type Date Words Alnylam Presents New Pre-Clinical Data on RNAi Therapeutics at Oligonucleotides Therapeutics Society (OTS) Meeting. Nov 5, 2009 1574 AVANIR Pharmaceuticals Presents Detailed Zenvia Confirmatory Phase III Results in Late-Breaker Session at American Neurological Association Meeting. Oct 13, 2009 2026 Pharmaceutical patents: incentives for research and development or marketing? Brekke, Kurt R.; Straume, Odd Rune Oct 1, 2009 13191 The vitamin debate goes on ... and both sides are right. Sep 1, 2009 1079 UAS Laboratories: prizing the power of probiotics. Company overview Sep 1, 2009 826 ArginMax may increase female libido. Clinical report Sep 1, 2009 199 Germany: Evotec completes Research Support stake purchase. Sep 1, 2009 170 Germany : Evotec completes Research Support stake purchase. Sep 1, 2009 165 Low cholesterol can increase risk to cancer: Study. Aug 6, 2009 483 Drug research leaves Astra with a headache. Jul 13, 2009 161 AVANIR Pharmaceuticals Announces the Complete Enrollment of the Zenvia Open Label Extension Study. Clinical report Jul 6, 2009 1069 Does a helmet versus oronasal mask improve NIPPV? Patrick, Herbert Jul 1, 2009 1257 New Study Results Verify That PNH Cells Are Found in Majority of Patients with Bone Marrow Failure Syndromes. Clinical report May 29, 2009 1641 Researchers to Report on the Investigational Use of Alexion's Soliris[R] (Eculizumab) to Prevent Antibody-Mediated Rejection in High-Risk Kidney Transplant Patients. May 28, 2009 555 Emisphere Technologies Reports Encouraging Data from Independent Clinical Study Assessing the Effects of Oral GLP-1 and PYY3-36, Combined with Eligen[R] Technology on Appetite Suppression. Clinical report May 26, 2009 698 AVEO Pharmaceuticals' Scientific Advisory Board Members Recognized for Contributions to Cancer Research and Medicine. May 13, 2009 627 Inspire Announces Poster Presentations at 2009 Association for Research in Vision and Ophthalmology Annual Meeting. May 4, 2009 515 Agios Pharmaceuticals Highlights Extensive Cancer Metabolism Research at AACR. Apr 30, 2009 644 Roche NimbleGen and Sigma-Aldrich Collaborate to Advance Epigenetic Research. Apr 21, 2009 848 Calistoga Pharmaceuticals Announces Presentations on CAL-101 and CAL-120 at the American Association for Cancer Research Annual Meeting. Apr 21, 2009 376 Curis Announces Presentations at American Association for Cancer Research Annual Meeting 2009. Apr 9, 2009 405 Alnylam and Collaborators at MIT Publish New In Vivo Research on Systemic Delivery of RNAi Therapeutics. Mar 5, 2009 1098 India: Centre may inject $2 bn/yr into drug research. Mar 5, 2009 149 Roche NimbleGen Microarrays Selected as Technology of Choice for the Neuromuscular Disorder -Chip Consortium. Feb 26, 2009 873 When "nothing" works better than "something". Feb 1, 2009 1043 India : Navin Fluorine sets up research centre at Surat plant. Jan 5, 2009 106 Alnylam Publishes Pre-Clinical Research on Direct CNS Delivery of RNAi Therapeutics. Dec 19, 2008 968 PBMI Research Shows Employers Still Highly Satisfied with Their PBMs. Dec 8, 2008 405 NPS Pharmaceuticals Initiates Phase 3 'STEPS' Study to Confirm GATTEX[TM] Reduces Parenteral Nutrition Dependence in Short Bowel Syndrome. Dec 2, 2008 1398 Dr. Etienne Gagnon Receives CIHR BIOTECanada/Schering-Plough Canada Fellowship for Innovative Cancer Research. Nov 20, 2008 404 Alnylam and Collaborators Publish Research on a New Class of Chemically Modified RNAi Therapeutics that Target Two Distinct Cellular Mechanisms. Nov 3, 2008 1305 Frontiers in Health Policy Research. Sep 22, 2008 1247 Calando Pharmaceuticals Phase II Clinical Study Opens to Patient Enrollment. Clinical report Sep 11, 2008 776 Alternative Alzheimer's drug research. Sep 1, 2008 326 Panacos Announces Results of Bevirimat Prospective Study, which Confirm Patient Response Predictors. Clinical report Jun 17, 2008 1130 Bad research. Jun 2, 2008 352 FAA bans anti-smoking drug; Pilots, controllers not to use Chantix; Study found side effects that raised concern. May 22, 2008 566 Massachusetts Biotechnology Council Issues $1.4 Million 'Cancer Research Challenge' to Support American Cancer Society. May 20, 2008 991 Diversity missing from research. Muirhead, Greg May 1, 2008 491 Pharma developments: UF study: Drug found that unlocks cardio benefits of ACE2. May 1, 2008 2522 Alnylam and Collaborators Publish Research on the Immunostimulatory Properties and Mechanisms of Certain siRNAs in Mammalian Cells. Apr 28, 2008 1028 Spectrum Pharmaceuticals Provides an Update on Ozarelix in BPH. Clinical report Apr 22, 2008 1598 Research trouble. Apr 21, 2008 218 GenVec Presents New Research on TNFerade(TM). Apr 15, 2008 602 NovaDel Announces Positive Data from Pilot Pharmacokinetic Study Comparing Tizanidine Oral Spray to Zanaflex(R) Tablets. Report Apr 7, 2008 1264 Patients Treated with Merck's Investigational Extended-Release Niacin/Laropiprant (CORDAPTIVE(TM)) Reported Significantly Less Flushing Than Patients Treated with Niaspan(TM) in Phase III Study. Mar 31, 2008 1499 Boffin's pounds 100,000 for MRSA research. Mar 13, 2008 115 New Technique Involving Roche's LightCycler(R) 480 Instrument Enables Efficient and Economic Studies on RNA Editing. Mar 4, 2008 503 Arrowhead Streamlines Business Model of Nanobiotech Subs, Calando Pharmaceuticals and Insert Therapeutics. Feb 28, 2008 749 AVANIR Announces Progress on Zenvia(TM) Development. Clinical report Feb 5, 2008 1139 Pooled Phase 3 Study of Nplate(TM) (Romiplostim) in Adult Patients with Chronic ITP Published in The Lancet. Jan 31, 2008 2097 FDA issues early communication about ongoing review of Vytorin. Pickett, Joseph Report Jan 29, 2008 592 FDA requiring suicide studies in drug trials. Pickett, Joseph Report Jan 29, 2008 779 New Research Reports Physicians Value Highly Educated Pharmaceutical Representatives: Education - Not Regulation - Needed for Improved Physician/Representative Interaction. Jan 22, 2008 683 Taking care of business: are corporate-funded research programs influencing the search for environmental solutions? Huber, Sonya Jan 1, 2008 2368 Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints. Clinical report Dec 8, 2007 2152 Research Confirms Correlation between PBM Transparency and Employer Satisfaction. Nov 29, 2007 362 Encouraging Preliminary Data from TNFerade(TM) Phase II Rectal Cancer Study Presented at ASTRO Meeting. Clinical report Oct 31, 2007 582 Merck's Investigational CETP-Inhibitor, MK-0859 (anacetrapib), Produced Positive Effects on Lipids with No Observed Blood Pressure Changes in Phase IIb Study. Oct 4, 2007 944 Alnylam and Collaborators Publish New Paper in the Journal Nature on the In Vivo Efficacy and Safety of RNAi Therapeutics. Sep 26, 2007 1049 Alkermes and Indevus Announce Positive Results from Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD. Sep 26, 2007 1263 Destination: India - Drug Discovery & Development. Sep 17, 2007 1089 Next Pharmaceuticals Announces Results of Relora(R) Open Label Study. Report Sep 4, 2007 419 ROCS Outperforms Docking for 3D Virtual Screening in Merck Study. Aug 1, 2007 320 Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine. Jun 21, 2007 942 Alnylam Establishes New Research Program on Delivery of RNAi Therapeutics at MIT's Center for Cancer Research. May 9, 2007 994 Next Pharmaceuticals Reveals Nexrutine(R) Prevents Prostate Cancer Progression in Pre-clinical Animal Model. May 2, 2007 543 Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R). Apr 19, 2007 741 INNOVIVE Pharmaceuticals Announces Additional Data Presentations at American Association for Cancer Research Annual Meeting. Apr 12, 2007 253 Merck biologics manufacturing site hit with 4-item 483 for comparability study flaws. Apr 1, 2007 995 Merck biologics manufacturing site nets 4-item 483 for comparability study flaws. Apr 1, 2007 768 OneWorld Health Selects Odyssey Research for Phase 4 Study in India. Mar 28, 2007 721 Alnylam and Stanford University Scientists Discover New Role for microRNAs (miRNAs) in T Cell Biology and Immunity. Mar 22, 2007 1298 Blair backs animal-human stem cell research. Mar 2, 2007 199 Entelos Announces Continued Research with Pfizer. Feb 22, 2007 218 New England Journal of Medicine Study Finds Uterine Fibroid Embolization Provides Equivalent Quality-of-Life Benefit, Allows Faster Recovery Time, and Was Significantly More Cost Effective Compared to Hysterectomy and Myomectomy. Jan 29, 2007 1074 Indena: a natural at botanical production. Company overview Jan 1, 2007 658 AmpliMed(R) to Present Positive Phase I Study Results for Amplimexon(R) (imexon for inj.) in Patients with Advanced Solid Tumors. Nov 10, 2006 779 Research Reveals More Women with Fibroids Discussing Uterine Fibroid Embolization (UFE) with Their Physicians. Nov 8, 2006 1085 Alnylam and Yale University Scientists Demonstrate Therapeutic Silencing of Disease Target Associated with Acute Lung Injury Using RNAi. Nov 6, 2006 1166 Research Shows PBM Transparency Influences Employer Satisfaction. Nov 6, 2006 449 Verdure to focus on bionutritional research; acquires Geni Herbs' branded ingredients. Brief article Nov 1, 2006 136 Nexrutine inhibits prostate cancer cell proliferation. Brief article Nov 1, 2006 110 LinumLife proven bioavailable. Brief article Nov 1, 2006 89 Lutein increases skin hydration, elasticity and lipid levels. Brief article Nov 1, 2006 251 NeurogesX Phase 3 Study in Post-Herpetic Neuralgia Meets Primary Endpoint. Oct 18, 2006 714 Fingolimod gets green light for phase 3 study. Oct 1, 2006 52 Review faults scientist's conduct; NIH researcher; Failure to report drug-firm fees cited; hearing on issue due. Sep 10, 2006 783 Study Results Point to Possible Application of Inovio's Electroporation-Based Therapy in Conjunction with Surgery to Treat Solid Tumor Margins. Sep 5, 2006 810 Advanced Viral Research (ADVR) Announces Results of Topical Animal Study Indicating AVR 118 Accelerates Wound Healing. Aug 7, 2006 404 Teva Initiates Phase III Study to Confirm Increased Efficacy of Higher Dose of Glatiramer Acetate for the Treatment of Relapsing-Remitting Multiple Sclerosis; Study to Confirm Phase II Results Showing Reduced Relapses and Lesions. Jul 27, 2006 1091 Meta-analysis substantiates Padma Basic for PAD. Brief article Jul 1, 2006 157 Merck Stands Behind Original APPROVe Study Results; Increased Relative Risk Observed Beginning After 18 Months. Jun 26, 2006 969 Savient's Puricase(R) (PEG-uricase) Phase 2 Results Show Powerful Anti-hyperuricemic Activity in Treatment-Failure Gout Patients. Jun 22, 2006 1938 Stimulating hormone production may help older folks; UW drug study; Participants had more energy, better balance, greater muscle mass. Jun 22, 2006 722 Meeting explores pricing of pharmaceutical products. Jun 1, 2006 872 Study Shows Glycominds' Glycan Markers Predict Complications and Need for Surgery in Crohn's Disease Patients. May 24, 2006 432 Bug Zapper: novel drug kills resistant bacteria. Seppa, N. May 20, 2006 533 UK. Brief article Apr 30, 2006 79 Hidden benefits of a collaborative R&D alliance in the pharmaceutical industry: the case of Schering AG and Novo Nordisk A/S. Brockstedt, Ekkehard; Carr, Chris Oct 1, 2005 2337